Analysis
Corrected Sep 29, 2026: an earlier version described Anthropic's IPO as a recent listing near a $2 trillion post-money valuation. Anthropic has not gone public; Reuters reports its planned IPO could value it at more than $2 trillion, with the debut likely after the November midterm elections.
This fall's IPO pipeline is shaped like a barbell, and the gap in the middle is the actual story. At one end: OpenAI targeting roughly a $1 trillion IPO valuation and Anthropic's planned listing, which Reuters reports could value it at more than $2 trillion, alongside Nscale's $25 billion AI-infrastructure IPO track and Oura's $15.6 billion consumer-hardware debut. At the other end: a wave of SEC S-1 filings dominated by acquisition corps and micro-cap names -- Elevation Acquisition Group, TCGX Acquisition Corp II, Southport Acquisition Corp II, and Bluerock Acquisition Corp II all filed or amended registration statements in the same late-September window.
“This fall's IPO pipeline is shaped like a barbell, and the gap in the middle is the actual story.”
What's largely missing is the middle: conventional $1 billion to $20 billion venture-backed tech companies going public on a normal growth story, without either a trillion-dollar AI narrative or a blank-check-shell structure behind them. That middle tier used to anchor a typical IPO class -- think the 2021 wave of Confluent, HashiCorp and UiPath, mid-cap software names that priced on straightforward growth multiples rather than AI infrastructure or frontier-lab narratives. Its relative absence this fall leaves most well-run, mid-sized startups without a clean recent public comp to price a future listing against, forcing bankers to either stretch AI-infrastructure comps that don't really fit or fall back on multi-year-old data.
A SPAC-heavy filing wave has historically been a soft signal, not a strong one -- SPAC sponsors are motivated by looming redemption deadlines to find any viable target, not necessarily the strongest one, which is part of why aftermarket performance for SPAC-merged companies has trailed traditional IPOs across most cycles going back to 2021. That history argues for reading this fall's filing volume as a symptom of sponsor urgency rather than confidence that a broad universe of quality targets exists.
For growth-stage investors, the practical read is patience: the window is genuinely open right now for category-defining mega-caps and for desperate shells willing to take almost any deal, but thin for the broad middle where most VC portfolios actually need an exit. That gap won't close until enough mid-sized, non-AI-narrative companies decide the public markets are worth the scrutiny, which so far in 2026 most have chosen to avoid in favor of another private round.